Medpace Holdings, Inc. Operating Lease Right-of-Use Assets
Medpace Holdings, Inc. (MEDP) had Operating Lease Right-of-Use Assets of $125.85 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-07-23
- 2026-06-30: Operating Lease, Right-of-Use Asset $125.85M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $126.81M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $117.81M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $123.59M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $125.85M 10-Q · filed 2026-07-23 | |
| 2026-03-31 | $126.81M 10-Q · filed 2026-04-23 | |
| 2025-12-31 | $117.81M 10-Q · filed 2026-07-23 | |
| 2025-09-30 | $123.59M 10-Q · filed 2025-10-23 | |
| 2025-06-30 | $129.50M 10-Q · filed 2025-07-22 | |
| 2025-03-31 | $129.86M 10-Q · filed 2025-04-22 | |
| 2024-12-31 | $128.65M 10-K · filed 2026-02-10 | |
| 2024-09-30 | $130.55M 10-Q · filed 2024-10-22 | |
| 2024-06-30 | $134.00M 10-Q · filed 2024-07-23 | |
| 2024-03-31 | $138.80M 10-Q · filed 2024-04-23 | |
| 2023-12-31 | $144.80M 10-K · filed 2025-02-11 | |
| 2023-09-30 | $144.15M 10-Q · filed 2023-10-24 | |
| 2023-06-30 | $139.86M 10-Q · filed 2023-07-25 | |
| 2023-03-31 | $143.31M 10-Q · filed 2023-04-25 | |
| 2022-12-31 | $139.07M 10-K · filed 2024-02-13 | |
| 2022-09-30 | $139.07M 10-Q · filed 2022-10-25 | |
| 2022-06-30 | $135.39M 10-Q · filed 2022-07-26 | |
| 2022-03-31 | $141.64M 10-Q · filed 2022-04-26 | |
| 2021-12-31 | $129.56M 10-K · filed 2023-02-14 | |
| 2021-09-30 | $125.43M 10-Q · filed 2021-10-26 | |
| 2021-06-30 | $110.73M 10-Q · filed 2021-07-27 | |
| 2021-03-31 | $112.27M 10-Q · filed 2021-04-27 | |
| 2020-12-31 | $113.81M 10-K · filed 2022-02-15 | |
| 2020-09-30 | $109.53M 10-Q · filed 2020-10-27 | |
| 2020-06-30 | $113.57M 10-Q · filed 2020-07-28 | |
| 2020-03-31 | $58.67M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $52.15M 10-K · filed 2021-02-16 | |
| 2019-09-30 | $52.48M 10-Q · filed 2019-10-29 | |
| 2019-06-30 | $51.81M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $52.15M 10-Q · filed 2020-04-29 | $53.63M 10-Q · filed 2019-04-30 |
| 2019-01-01 | $51.85M 10-K · filed 2022-02-15 | |
| 2018-12-31 | $0.00 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |